-
Monascus purpureus Red Yeast Rice: A Review of the in vitro and in vivo Pharmacological Activities, Studies in Humans, and Case Reports
02 Sep 2025 16:45 GMT
… moderately hypercholesterolemic, nonsmoking, pharmacologically untreated subjects. The patients … health supplements, including Taisho Chinese herbal gastrointestinal medicine … Doctoral Program in Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, …
-
Mid-Size Pharmaceuticals Market Analysis 2025 – Insights For Long-Term Investment & Planning
30 Jun 2025 10:28 GMT
… , Aurobindo Pharma Limited., Cipla Limited, Hikma Pharmaceuticals, Endo International plc, Taisho Pharmaceutical Holdings Co … . Ltd., BioMarin Pharmaceutical Inc., Mallinckrodt …
-
Investors take issue with Taisho Pharma’s buyout price
15 Jul 2024 13:37 GMT
… have decided to contest Taisho Pharma’s recently announced management … the current offer price.
Taisho announced plans for an … it is considering suing Taisho Pharma directors and special committee … has a small prescription pharma business with products like …
-
Japan's Taisho Pharma faces claim over buyout price in court, Nikkei reports
14 Jul 2024 22:27 GMT
… are contesting the pricing of Taisho Pharmaceutical Holdings' management … newspaper reported on Monday.
Taisho's founding family … that the value of Taisho Pharma';s property holdings … , the report added.
Taisho Pharma could not immediately be reached …
-
Japan's Taisho Pharma faces claim over buyout price from Curi RMB, Oasis
14 Jul 2024 22:25 GMT
… are contesting the pricing of Taisho Pharmaceutical Holdings' management buyout in … forced divestment as minority shareholders.
Taisho Pharma announced plans for the management …
-
Oasis says it opposes Taisho Pharma';s $5 bln management buyout
12 Feb 2024 10:53 GMT
… , said it is opposed to Taisho Pharmaceutical';s $5 billion management … 55 per cent premium to Taisho's share price before … in March that would consolidate Taisho's shares - a … that Oasis has been a Taisho shareholder "for a long …
-
Curi RMB Capital Opposes Taisho Pharmaceutical HD’s Management Buyout
21 Feb 2024 01:45 GMT
… management buyout (“the MBO”) of Taisho Pharmaceutical Holdings Co., Ltd. (4581 … JP, TSE Standard, “Taisho”) because we believe the MBO … per share. We suspect Taisho’s excess cash, including … meeting of shareholders held by Taisho in March.
(End)
About …
-
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
22 Jan 2025 18:00 GMT
… & Dohme Corp., Navitor Pharmaceuticals, Inc., Taisho Pharmaceutical Co., Ltd., GH Research Limited … , Novartis Pharmaceuticals, Reckitt Benckiser LLC, Relmada …
-
Japan's Taisho Pharma to go private after successful tender offer
16 Jan 2024 22:28 GMT
TOKYO -- Taisho Pharmaceutical Holdings will be delisted following … buyer a 73% stake in Taisho.
-
Taisho Pharmaceutical Management Offers Buyout at 55% Premium
24 Nov 2023 14:48 GMT
(Bloomberg) -- Taisho Pharmaceutical Holdings Co.’s management … biggest block of shares in Taisho. Founded in 1912, … Shokichi Uehara made Taisho a leading provider of everything … the reason for privatization.
Taisho shares have been underperforming the …
About
© 1995-2026